Fauna Bio
company
About
Fauna Bio is a biotechnology company leveraging the science of hibernation to improve healthcare for humans.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $229K
- Industries
- Biotechnology,Health Care,Hospital,Medical
- Founded date
- Jan 1, 2018
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Fauna Bio is developing new ways to treat human diseases, such as heart disease and neurodegenerative disease, by adopting mechanisms animals have developed for traits such as hibernation and deep-diving. Founded by three scientists who have intimate knowledge of the best science and resources from the field of non-model organisms, Fauna Bio leverages data from hundreds of species in order to help develop pre-clinical and early clinical testing for new therapeutics targeting human diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$4.32M
Fauna Bio has raised a total of
$4.32M
in funding over 2 rounds. Their latest funding was raised on
Mar 4, 2021 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 4, 2021 | Grant | — | 1 |
National Human Genome Research Institute
|
— | Detail |
| Oct 10, 2019 | Grant | $229K | 1 |
National Institutes of Health
|
— | Detail |
| Apr 11, 2019 | Seed | $4.10M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
2
3
Fauna Bio is funded by 3 investors.
National Human Genome Research Institute
and National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Human Genome Research Institute
|
Yes | Grant |
|
National Institutes of Health
|
Yes | Grant |
Beagle Ventures
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
